REFERENCES
- Dietl J. The pathogenesis of pre-eclampsia: new aspects. J Perinat Med. 2000; 28: 464–471
- Jeunemaitre X, Lifton R, Hunt SC, et al. Molecular basis of hypertension: Role of angiotensinogen. Cell 1992; 71: 169–180
- Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343–1346
- Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, et al. Molecular basis of human hypertension: Role of angiotensinogen. Cell 1992; 71: 169–180
- Sugimoto K, Katsuya T, Ohkubo T, Hozawa A, Yamamoto K, Matsuo A, Rakugi H, Tsuji I, Imai Y, Ogihara T. Association between angiotensin II type 1 receptor gene polymorphism and essential hypertension: the Ohasama Study. Hypertens Res 2004; 27: 551–556
- Dudley CR, Keavney B, Stratton IM, Turner RC, Ratcliffe PJ. U.K. Prospective Diabetes Study. XV: relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 1995; 48: 1907–1911
- Giner V, Poch E, Bragulat E, Oriola J, Gonzalez D, Coca A, Sierra De La. Renin-angiotensin system genetic polymorphisms and salt sensitivity in essential hypertension. Hypertension 2000; 35: 512–517
- Rigat B, Hubert C, Corvol P, et al. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992; 20(6)1433
- Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, Farrington PF, Ogasawara M, Suzumori K, Tomoda S, et al. A molecular variant of angiotensinogen associated with preeclampsia. Nature Genet 1993; 4: 59–61
- Morgan T, Craven C, Lalouel JM, Ward K. Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua. Am J Obstet Gynecol 1999; 180: 95–102
- Tamura T, Johanning GL, Goldenberg R, Johnston KE, DuBard MB. Effect of angiotensin-converting enzyme gene polymorphism on pregnancy outcome. Obstet Gynecol 1996; 88: 497–502
- Morgan L, Foster F, Hayman R, Crawshaw S, Baker PN, Broughton Pipkin F, Kalsheker N. Angiotensin-converting enzyme insertion-deletion polymorphism in normotensive and preeclamptic pregnancies. J Hyperten 1999; 17: 765–768
- Doria A, Ji L, Warram JH, Krolewski AS. DdeI polymorphism in the AGTR1 gene. Hum Mol Genet 1994; 3: 1444
- Sutherland A, Cooper DW, Howie PW, Liston WA, MacGillivray I. The incidence of severe preeclampsia amongst mothers and mothers in-law of preeclamptic and controls. Br J Obstet Gynaecol 1981; 88: 785–791
- ACOG technical bulletin. Hypertension in pregnancy. Number 219—January 1996. Int J Gynaecol Obstet. May, 1996; 53(2)175–183
- van Ittersum FJ, de Man AM, Thijssen S, de Knijff P, Slagboom E, Smulders Y, Tarnow L, Donker AJ, Bilo HJ, Stehouwer CD. Genetic polymorphisms of the renin–angiotensin system and complications of insulin-dependent diabetes mellitus. Nephrol Dial Transplant 2000; 15: 1000–1007
- Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med. 1989; 320: 1161–1165
- Earle K, Walker J, Hill C, Viberti G. Familial clustering of cardiovascular disease in patients with insulin dependent diabetes and nephropathy. N Engl J Med. 1992; 326: 673–677
- Freire MB, Ferreira SR, Vivolo MA, Oliveira JM, Zanella MT. Familial hypertension and albuminuria in normotensive type I diabetic patients. Hypertension 1994; 23(Suppl I)1256–1258
- Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343–1346
- Fujisawa T, Ikegami H, Shen GQ, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, Ueda H, Rakugi H, Higaki J. Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 1995; 18: 983–985
- Wang Y, Ng MC, So WY, Tong PC, Ma RC, Chow CC, Cockram CS, Chan JC. Prognostic effect of insertion/deletion polymorphism of the ACE gene on renal and cardiovascular clinical outcomes in Chinese patients with type 2 diabetes. Diabetes Care 2005; 28: 348–354